BlackRock, Inc. 13D and 13G filings for BioLife Solutions, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-23 4:13 pm Sale |
2023-12-31 | 13G | BioLife Solutions, Inc. BLFS |
BLACKROCK INC BLK |
5,424,116 12.300% |
-53,010 (-0.97%) |
Filing |
| 2023-01-26 08:52 am Unchanged |
2022-12-31 | 13G | BioLife Solutions, Inc. BLFS |
BLACKROCK INC BLK |
5,477,126 12.800% |
0 (Unchanged) |
Filing |
| 2023-01-20 09:43 am Purchase |
2022-12-31 | 13G | BioLife Solutions, Inc. BLFS |
BLACKROCK INC BLK |
5,477,126 12.800% |
583,923 (+11.93%) |
Filing |
| 2022-07-08 4:56 pm Purchase |
2022-06-30 | 13G | BioLife Solutions, Inc. BLFS |
BLACKROCK INC BLK |
4,893,203 11.500% |
1,238,146 (+33.87%) |
Filing |
| 2022-02-01 5:08 pm Sale |
2021-12-31 | 13G | BioLife Solutions, Inc. BLFS |
BLACKROCK INC BLK |
3,655,057 8.800% |
-873,666 (-19.29%) |
Filing |
| 2021-09-09 4:20 pm Purchase |
2021-08-31 | 13G | BioLife Solutions, Inc. BLFS |
BLACKROCK INC BLK |
4,528,723 11.100% |
4,528,723 (New Position) |
Filing |